Step Pharma is a biotechnology company discovering and developing proprietary small molecule therapeutics for the treatment of auto-immune diseases. Step’s lead program is selective modulators against specific immune cell populations which are the main drivers of auto-immune diseases.

Our Company

Step Pharma Completes €14.5 million Series A Financing with Additional New Investor

Paris, France, 21 November 2017 – Step Pharma today announced the closing of a Series A financing totalling €14.5 million. Pontifax joined existing investors led by Kurma Partners, and including Bpifrance (Fonds Biothérapies Innovantes et Maladies Rares),…

Contact us for more information

Our administration office will be happy to contact you about advanced inquiries and to address you to our expert office: